Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

Background: Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting risk of reinfection and durability of vaccine protection. Methods: This is a prospective, monocentric, longitudinal, cohort clinical study. Healthcare workers (HCW) from Strasbourg University Hospital were enr...

Full description

Bibliographic Details
Main Authors: Floriane Gallais, Pierre Gantner, Timothée Bruel, Aurélie Velay, Delphine Planas, Marie-Josée Wendling, Sophie Bayer, Morgane Solis, Elodie Laugel, Nathalie Reix, Anne Schneider, Ludovic Glady, Baptiste Panaget, Nicolas Collongues, Marialuisa Partisani, Jean-Marc Lessinger, Arnaud Fontanet, David Rey, Yves Hansmann, Laurence Kling-Pillitteri, Olivier Schwartz, Jérome De Sèze, Nicolas Meyer, Maria Gonzalez, Catherine Schmidt-Mutter, Samira Fafi-Kremer
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:EBioMedicine
Subjects:
SARS-CoV-2
COVID-19
Immunity
Neutralizing antibodies
Reinfection
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003546

Internet

http://www.sciencedirect.com/science/article/pii/S2352396421003546

Similar Items